Efficacy and Safety of High-Dose Multimatrix Mesalazine in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of High-Dose Multimatrix Mesalazine in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis.
Authors: Shimizu T; Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan., Iwama I; Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan., Kakiuchi T; Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan., Abukawa D; Department of Gastroenterology and Hepatology, Miyagi Children's Hospital, Sendai, Miyagi, Japan., Kumagai H; Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan., Iwata N; Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Aichi, Japan., Takatsu M; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan., Nishimura K; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan., Matsuda A; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan., Hayashi K; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan., Mizuochi T; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Source: Pediatric gastroenterology, hepatology & nutrition [Pediatr Gastroenterol Hepatol Nutr] 2026 May; Vol. 29 (3), pp. 220-231. Date of Electronic Publication: 2026 Apr 29.
Publication Type: Journal Article
Journal Info: Publisher: Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition Country of Publication: Korea (South) NLM ID: 101590471 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2234-8646 (Print) Linking ISSN: 22348840 NLM ISO Abbreviation: Pediatr Gastroenterol Hepatol Nutr Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first